A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : GSK-3 / glycogen synthase kinase-3

[Related PubMed/MEDLINE]
Total Number of Papers: 2008
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   GSK-3  (>> Co-occurring Abbreviation)
Long Form:   glycogen synthase kinase-3
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2022 2,5-Dimethylcelecoxib attenuates cardiac fibrosis caused by cryoinjury-induced myocardial infarction by suppressing the fibroblast-to-myofibroblast transformation via inhibition of the TGF-β signaling pathway. alpha-SMA, CMI, CTGF, DM-C, FMT, TGF
2022 A glycogen synthase kinase 3-like kinase MpGSK regulates cell differentiation in Marchantia polymorpha. ---
2022 A non-catalytic scaffolding activity of hexokinase 2 contributes to EMT and metastasis. AKAP, HK2
2022 An in vivo drug repurposing screen and transcriptional analyses reveals the serotonin pathway and GSK3 as major therapeutic targets for NGLY1 deficiency. NGLY1
2022 Angiotensin II regulates mitochondrial mTOR pathway activity dependent on acyl CoA synthetase 4 in adrenocortical cells. ACSL4, Ang II
2022 Anti-Inflammatory Effect of IKK-Activated GSK-3β Inhibitory Peptide Prevented Nigrostriatal Neurodegeneration in the Rodent Model of Parkinson's Disease. IKK, PD
2022 Assessing Bioavailability and Bioactivity of 4-Hydroxythiazolidine-2-Thiones, Newly Discovered Glucosinolate Degradation Products Formed During Domestic Boiling of Cabbage. allyl HTT, NQO1
2022 Beta 2 adrenergic receptor and mu opioid receptor interact to potentiate the aggressiveness of human breast cancer cell by activating the glycogen synthase kinase 3 signaling. MOR
2022 Brassinosteroids promote thermotolerance through releasing BIN2-mediated phosphorylation and suppression of HsfA1 transcription factors in Arabidopsis. BIN2, BRs
10  2022 Canonical Wnt signaling induces focal adhesion and Integrin beta-1 endocytosis. FA, ITGbeta1, MVBs
11  2022 Deconvoluting signals downstream of growth and immune receptor kinases by phosphocodes of the BSU1 family phosphatases. BIK1, BRI1, BSU1, FLS2, LRR-RKs, MAP
12  2022 Dysregulation of multiple signaling pathways: A possible cause of cerebral palsy. CP
13  2022 Effects of lithium on aggression in Drosophila. ---
14  2022 Elevation of Hyaluronan Synthase by Magnesium Supplementation Mediated through the Activation of GSK3 and CREB in Human Keratinocyte-Derived HaCaT Cells. CREB, HA, HAS, NIPAL4
15  2022 Elraglusib (9-ING-41), a selective small-molecule inhibitor of glycogen synthase kinase-3 beta, reduces expression of immune checkpoint molecules PD-1, TIGIT and LAG-3 and enhances CD8+ T cell cytolytic killing of melanoma cells. ---
16  2022 Evidence for investigating GSK-3 inhibitors as potential therapeutics for severe COVID-19. LPS, TLRs
17  2022 Fibroblast GSK-3α Promotes Fibrosis via RAF-MEK-ERK Pathway in the Injured Heart. Ad-GSK-3alphaS21A
18  2022 Fimasartan Ameliorates Deteriorations in Glucose Metabolism in a High Glucose State by Regulating Skeletal Muscle and Liver Cells. ATP, ELISA, GLUT-4, IRS-1, OCR, pAMPK, PPARdelta
19  2022 Genome-Wide Characterization and Phylogenetic Analysis of GSK Genes in Maize and Elucidation of Their General Role in Interaction with BZR1. ZmGSKs
20  2022 Gli Phosphorylation Code in Hedgehog Signal Transduction. Ci, CK1, Fu, Hh, PKA, Ulk
21  2022 Glutaminolysis is required in maintaining immune regulatory functions in B cells. ---
22  2022 Glycogen kinase 3 inhibitor nanoformulation as an alternative strategy to inhibit PD-1 immune checkpoint. CAR, PD-1
23  2022 Glycogen Synthase Kinase 3: Ion Channels, Plasticity, and Diseases. S/T
24  2022 Glycogen synthase kinase GSK3α promotes tumorigenesis by activating HIF1/VEGFA signaling pathway in NSCLC tumor. ---
25  2022 Glycogen Synthase Kinase-3 Isoform Variants and Their Inhibitory Phosphorylation in Human Testes and Spermatozoa. LCR, SCO
26  2022 GSK-3β Inhibition in Birds Affects Social Behavior and Increases Motor Activity. ---
27  2022 GSK3 inhibition circumvents and overcomes acquired lorlatinib resistance in ALK-rearranged non-small-cell lung cancer. ALK, DTP, NSCLCs, TKI
28  2022 GSK3 Is a Central Player in Retinal Degenerative Diseases but a Challenging Therapeutic Target. ---
29  2022 Identification of an Epi-metabolic dependency on EHMT2/G9a in T-cell acute lymphoblastic leukemia. ALL, Sesn2
30  2022 Importance of Indazole against Neurological Disorders. AD, LRRK2, MAO, PD
31  2022 Inhibition of the Glycogen Synthase Kinase 3 Family by the Bikinin Alleviates the Long-Term Effects of Salinity in Barley. BRs
32  2022 Insulin signaling as a therapeutic mechanism of lithium in bipolar disorder. PKC
33  2022 Isoform-Specific Role of GSK-3 in High Fat Diet Induced Obesity and Glucose Intolerance. HFD
34  2022 Low dose lithium supplementation promotes adipose tissue browning and sarco(endo)plasmic reticulum Ca2+ ATPase uncoupling in muscle. iWAT, LiCl, UCP1
35  2022 Magnesium Supplementation Attenuates Ultraviolet-B-Induced Damage Mediated through Elevation of Polyamine Production in Human HaCaT Keratinocytes. CREB, UVB
36  2022 Magnesium-Assisted Cisplatin Inhibits Bladder Cancer Cell Survival by Modulating Wnt/β-Catenin Signaling Pathway. BIO, LC3-II
37  2022 Many faces and functions of GSKIP: a temporospatial regulation view. AD, PKA
38  2022 Medicinal plants with antimalarial activities mediated via glycogen synthase kinase-3 beta (GSK3β) inhibition. GSK-3beta
39  2022 Naphthoquinone as a New Chemical Scaffold for Leishmanicidal Inhibitors of Leishmania GSK-3. PKs
40  2022 Neuroprotective Properties of Minocycline Against Methylphenidate-Induced Neurodegeneration: Possible Role of CREB/BDNF and Akt/GSK3 Signaling Pathways in Rat Hippocampus. BDNF, CREB, FST, GPx, GR, IHC, IL-1beta, MPH, OFT, SOD
41  2022 Novel GSK-3 kinase inhibitor Pym-5 induces GSK-3β rather than GSK-3α-dependent melanogenesis in murine melanoma cells. ---
42  2022 OsCPL3 is involved in brassinosteroid signaling by regulating OsGSK2 stability. BR, BZR1
43  2022 Pathobiology and Therapeutic Relevance of GSK-3 in Chronic Hematological Malignancies. c-Myc
44  2022 PET imaging of glycogen synthase kinase-3 in pancreatic cancer xenograft mouse models. ---
45  2022 Pharmacological suppression of glycogen synthase kinase-3 reactivates HIV-1 from latency via activating Wnt/β-catenin/TCF1 axis in CD4+ T cells. 6BIO, LRAs
46  2022 Pharmacotherapy of Alzheimer's disease: an overview of systematic reviews. AD, ChEIs, NSAIDs, RoB, ROBIS, SR
47  2022 Phytochromes A and B Mediate Light Stabilization of BIN2 to Regulate Brassinosteroid Signaling and Photomorphogenesis in Arabidopsis. BR
48  2022 Proteome-wide cellular thermal shift assay reveals unexpected cross-talk between brassinosteroid and auxin signaling. CETSA MS
49  2022 Quantification of Hepatocellular Mitoses in a Toxicological Study in Rats Using a Convolutional Neural Network. BrdU, CNNs, LIs
50  2022 Re-Expression of ERα and AR in Receptor Negative Endocrine Cancers via GSK3 Inhibition. AR, DNMT, ER, ERa
51  2022 Recent clinical findings on the role of kinase inhibitors in COVID-19 management. BTK, CRS, JAK/STAT, p38 MAPK
52  2022 Regulation of Autophagy by the Glycogen Synthase Kinase-3 (GSK-3) Signaling Pathway. AMD, EIF4A3, PKC, TFEB
53  2022 Role of Glycogen Synthase Kinase-3 in Interferon-γ-Mediated Immune Hepatitis. IFN
54  2022 Selective GSK3β Inhibition Mediates an Nrf2-Independent Anti-inflammatory Microglial Response. NF-kappaB, Nrf2
55  2022 Silencing of Glycogen Synthase Kinase 3 Significantly Inhibits Chitin and Fatty Acid Metabolism in Asian Citrus Psyllid, Diaphorina citri. DEGs, RNAi, RT-qPCR
56  2022 Slit2/Robo1 signaling inhibits small cell lung cancer by targeting β-catenin signaling in tumor cells and macrophages. MDSCs, ROBO1, SCLC, SCLC-Y, SLIT2, TAMs, TGF-beta1, YAP1
57  2022 Specific Role for GSK3α in Limiting Long-Term Potentiation in CA1 Pyramidal Neurons of Adult Mouse Hippocampus. LTP
58  2022 Sperm-specific glycogen synthase kinase 3 is required for sperm motility and the post-fertilization signal for female meiosis II in Caenorhabditis elegans. MII, MSP
59  2022 Splicing-mediated activation of SHAGGY-like kinases underpinning carbon partitioning in Arabidopsis seeds. ---
60  2022 Suppression of nuclear GSK3 signaling promotes serine/one-carbon metabolism and confers metabolic vulnerability in lung cancer cells. ---
61  2022 Targeting Impaired Nutrient Sensing via the Glycogen Synthase Kinase-3 Pathway With Therapeutic Compounds to Prevent or Treat Dementia: A Systematic Review. AD, MCI
62  2022 The GSK-3 Inhibitor CT99021 Enhances the Acquisition of Spatial Learning and the Accuracy of Spatial Memory. LTD, MWM, NMDAR
63  2022 The GSK3 kinase and LZTR1 protein regulate the stability of Ras family proteins and the proliferation of pancreatic cancer cells. PC
64  2022 The Prophylactic and Multimodal Activity of Two Isatin Thiosemicarbazones against Alzheimer's Disease In Vitro. AD, ITSCs, PKB
65  2022 The Role of Glycogen Synthase Kinase-3 in the Regulation of Ribosome Biogenesis in Rat Soleus Muscle under Disuse Conditions. GS-1, PS
66  2022 The Tumor Suppressor Protein TRAF3 Modulates GSK3 Activity and Susceptibility of B Lymphoma Cells to GSK3 Inhibition. TRAF3
67  2022 Triiodothyronine Treatment reverses Depression-Like Behavior in a triple-transgenic animal model of Alzheimer's Disease. AD, APP, BMP-7, BW, MCT8, SERT, SOD2, TH
68  2022 Unraveling the Effects of GSK-3β Isoform Modulation against Limbic Seizures and in the 6 Hz Electrical Kindling Model for Epileptogenesis. ---
69  2021 A GSK3-SRF Axis Mediates Angiotensin II Induced Endothelin Transcription in Vascular Endothelial Cells. Ang II, SRF, VECs
70  2021 A novel GSK-3 inhibitor binds to GSK-3β via a reversible, time and Cys-199-dependent mechanism. ---
71  2021 Angiotensin II receptor 1 controls profibrotic Wnt/β-catenin signalling in experimental autoimmune myocarditis. AKAP-Lbc, Ang, ATR1, EAM, TGF-beta, WT
72  2021 Anti-inflammatory Potential of GSK-3 Inhibitors. GS, UDP-Glu
73  2021 Anxiety and cognitive-related effects of Δ 9-tetrahydrocannabinol (THC) are differentially mediated through distinct GSK-3 vs. Akt-mTOR pathways in the nucleus accumbens of male rats. Akt, NASh, THC
74  2021 Cell Biology of Canonical Wnt Signaling. APC, Wnt-STOP
75  2021 Central and peripheral emetic loci contribute to vomiting evoked by the Akt inhibitor MK-2206 in the least shrew model of emesis. DVC, s.c
76  2021 Ci/Gli Phosphorylation by the Fused/Ulk Family Kinases. Ci, CK1, Fu, Hh, PKA, Ulk
77  2021 Combination of Melatonin and Small Molecules Improved Reprogramming Neural Cell Fates via Autophagy Activation. ASCL1, BRN2, HDAC, JNK, LC3, MYT1L, NeuN, NSC, SOX2, VPA
78  2021 Deciphering the roles of glycogen synthase kinase 3 (GSK3) in the treatment of autism spectrum disorder and related syndromes. ASD, FXS, RTT
79  2021 Discovery of Novel Tacrine-Pyrimidone Hybrids as Potent Dual AChE/GSK-3 Inhibitors for the Treatment of Alzheimer's Disease. AChE, AD, GA
80  2021 Effect of Neurorepair for Motor Functional Recovery Enhanced by Total Saponins From Trillium tschonoskii Maxim. Treatment in a Rat Model of Focal Ischemia. CBF, CRMP2, MCAO, MRI, PI3K, SD
81  2021 Effects of Fruquintinib on the Pluripotency Maintenance and Differentiation Potential of Mouse Embryonic Stem Cells. LIF, MAPK, mESCs, VEGF
82  2021 Genistein suppresses the inflammation and GSK-3 pathway in an animal model of spontaneous ovarian cancer IL-6, IL-8, p-Akt, p-IRS-1, TNF-alpha, VEGF
83  2021 Glutamine promotes the generation of B10+ cells via the mTOR/GSK3 pathway. ---
84  2021 Glycogen synthase kinase 3 drives thymocyte egress by suppressing β-catenin activation of Akt. ---
85  2021 Glycogen Synthase Kinase 3 Regulates the Genesis of Displaced Retinal Ganglion Cells3. RGC
86  2021 Glycogen synthase kinase 3β/CCR6-positive bone marrow cells correlate with disease activity in multicentric Castleman disease-TAFRO. MCD-TAFRO
87  2021 Glycogen synthase kinase-3 (GSK-3) a magic enzyme: it's role in diabetes mellitus and glucose homeostasis, interactions with fluroquionlones. A mini-review. DM
88  2021 Glycogen Synthase Kinase-3 (GSK-3) Inhibitors as a New Lead for Treating Breast and Ovarian Cancer. ---
89  2021 Glycogen Synthase Kinase-3 (GSK-3) Regulation of Inhibitory Coreceptor Expression in T-cell Immunity. ---
90  2021 Glycogen Synthase Kinase-3: A Focal Point for Advancing Pathogenic Inflammation in Depression. MDD
91  2021 Glycogen synthase kinase-3beta inactivation promotes cervical cancerprogression, invasion, and drug resistance. AN, CSCC, DRCT, HPV, MMPs
92  2021 Glycogen synthesis and beyond, a comprehensive review of GSK3 as a key regulator of metabolic pathways and a therapeutic target for treating metabolic diseases. GS
93  2021 GSK-3 and Tau: A Key Duet in Alzheimer's Disease. AD, NFTs
94  2021 GSK-3 Inhibition Is Cytotoxic in Glioma Stem Cells through Centrosome Destabilization and Enhances the Effect of Radiotherapy in Orthotopic Models. GBM
95  2021 GSK-3 Inhibition Modulates Metalloproteases in a Model of Lung Inflammation and Fibrosis. BALF, IPF, MMP
96  2021 GSK-3 Inhibitors as New Leads to Treat Type-II Diabetes. ---
97  2021 GSK-3: a multifaceted player in acute leukemias. ---
98  2021 GSK-3β as a target for apigenin-induced neuroprotection against Aβ 25-35 in a rat model of Alzheimer's disease. AD
99  2021 GSK-3β Can Regulate the Sensitivity of MIA-PaCa-2 Pancreatic and MCF-7 Breast Cancer Cells to Chemotherapeutic Drugs, Targeted Therapeutics and Nutraceuticals. KD, WT
100  2021 GSK3 as a Regulator of Cytoskeleton Architecture: Consequences for Health and Disease. ---